2025 Q4 -tulosraportti
70 päivää sitten
‧31 min
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 386 | - | - | ||
| 1 189 | - | - | ||
| 5 425 | - | - | ||
| 2 142 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 20.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·1 t sittenNow both turnover and the share price really picked up speed..
·3 t sittenOnce again, don't forget that Elabs changed quarterly reports so that Q1 is not representative of activity and revenues. They subsequently changed the Q4 report which was seemingly positive to become correspondingly very bad afterwards where this effect will have a positive impact on Q1 and 2026 as a whole. High-level accounting trickery where they in reality get a positive effect 2 times. See the same people time and again disregard this in an attempt at positive publicity, optimism probably with personal gain as the goal. Be careful. I myself hold shares here. That being said, it can be interesting if the company delivers positive results and gets more contracts where they actually earn money and which contribute to real growth in the company..The market value is seemingly low if they deliver growth, positive ebita over time and build cash.- ·4 t sittenAny predictions for Q1 21.5? It looks like they are delivering growth towards 2025 and together with cost cuts, this should be good. Revenue Q1 2025 was 26,6MNOK and EBITDA -1,6 if I remember correctly.
·2 t sitten · MuokattuTwo contracts have been signed in Q1. Lenovo and Transsion. I expect pretty much the same in Revenue as in 2025. Am more excited about Cash revenues for Q1. A lot of cash came in Q1 2025 (could be POC). Possibly it's the fixed-price contracts. also I have a hope that revenue from the POC contract that came in 2025, was in Q4 and thus can give 12,6 mill in cash now in Q1. But if both these "hopes" come true, and they get a lot of cash in Q1, then it's very strange to carry out an emi at such a low price, when extra income comes in the report right after. Edit: info about POC is on page 30 in the annual report 
·22 t sittenIs there a rights issue coming here, has anyone caught anything? I can't find any info about this f, but it's taking an awfully long time? Info about the issue and possible rights issue probably came in early March. It must be said that I don't follow the company very closely anymore, but I saw that the share had a huge day yesterday, and started looking for info about this. It's fun when companies have green numbers, and then one gets curious :)·23 min sittenMajesty: What is stated in the annual report is not that something has been cancelled, it says, translated into Norwegian, slightly simplified: "The board of Elliptic Laboratories acknowledges that a private placement at a low price resulted in dilution for existing shareholders, but defends the transaction as necessary to secure low-risk capital. They believe this was in the common interest under prevailing market conditions" Common practice after a private placement is that the dilution is compensated with a repair issue, i.e., an opportunity for existing customers to "repair" some of the dilution by being able to buy shares on the same terms as those who participated in the private placement. The stock exchange has established guidelines for this, and they are quite strict about it. Nothing there about "the company has enough money, so they can choose to treat large and small shareholders differently". The share price in Elabs dipped under 2.85 but I don't know if that was enough for all shareholders to have been able to buy sufficient shares cheaper on the stock exchange than in the issue. We are talking about over 10 million shares in the repair issue, so it is of great importance whether the price was long enough below 2.85. This is what I'm wondering about, and the annual report doesn't say anything about this, it only says something about the considerations regarding dilution and the share price discount that was given. I think 30 mill kr in a repair issue is quite a lot to set as a plan, because the private placement was only double that. So I do believe the company sees a need for the money for something or other. It's not something you pull out of thin air, many other companies offer 20-25% in a repair issue, so they should have a need when they set it so high. If they hadn't had a need, they could have concluded with a much lower proportion for the private placement, and called this off quite shortly after the price dipped below, I think. It's wrong to say they don't need the money, we don't know that, there might be projects they want to realize in the future? New development costs a lot of money, as does work with new customers in the POC phase, which one hopes they are working on. There you get little in, but it costs a lot of expenses. I'm not going to talk down Elabs, just so that's clear, but I don't understand why there's a delay with information about the repair issue. It usually takes about 1 month, now 2 months have passed. Maybe they are waiting for prospectus approval from Finanstilsynet? Or it could be that it has been cancelled, but one usually gets a notification about that, it is essential information for shareholders. See for example Circio, where a repair issue of 25% of the private placement was cancelled due to the share price being 20% below the issue price: https://e24.no/bors/nyheter/a/304333 You can read more about the topic here: https://www.pwc.no/no/tjenester/kapitalmarkedstjenester/rettede-aksjeemisjoner.html·10 min sittenI interpret it as I described above and believe your translation does not capture all nuances. The time it has taken is a further argument against a repair issue now. The board has only been granted an authorization for such a repair issue and has never committed to carrying it out. Since over 10m shares traded around the issue price after publication, I would assume there is no obligation on the company to carry this out based on the principle of equal treatment. If they need more money, which I don't think they do right now, they have the authorization to raise money in other ways than a repair issue.- ·1 päivä sittenThere are now quite strong rumors that Apple Inc. is considering using Intel Corporation Foundry as a supplement to Taiwan Semiconductor Manufacturing Company (TSMC) for parts of its Apple Silicon production. Currently, this is at the "exploratory talks" stage, but the market is taking it very seriously. For Elabs, this could potentially be quite important – indirectly. Here's why: 1. Apple would be an enormous quality validation of Intel Foundry If Apple actually places production with Intel, it practically means that Intel has proven: competitive yield stable production advanced node technology (18A / 18A-P / 14A) high enough energy efficiency and volume capacity This is exactly what Intel needs to become a serious competitor to TSMC again. For companies already "designed in" to the Intel ecosystem – as Elliptic Labs is with AI Sensor Platform / virtual smart sensors – this could provide: greater credibility faster adoption by OEMs more design wins higher probability of volume 2. Elabs is exposed to Intel's AI-PC initiative In recent years, Elliptic Labs has gained entry into several Intel-based laptop designs through: AI Virtual Presence Sensor Human presence detection Context awareness Ultrasound-based sensor solutions Intel has tried to build an "AI PC" ecosystem around Core Ultra / Lunar Lake / Panther Lake. If Apple chooses Intel Foundry, the market will suddenly see Intel as: technologically relevant again strategically important for the USA a possible winner in the AI-chip race This could lift the entire Intel ecosystem — including partners like Elliptic Labs. The effect is: "Intel gets stronger → Intel ecosystem gains higher value → Intel partners can gain greater commercial weight." 4. Potential multiple effect for the Elabs stock The market loves "second-order beneficiaries". If the narrative becomes: Apple validates Intel Foundry Intel becomes an AI-chip challenger again Intel PC platforms gain momentum, then investors might start looking closer at small Intel-associated companies. That's where Elliptic Labs fits in perfectly: small market cap AI-edge narrative software margins already commercialized technology shipping in large OEM volumes This doesn't necessarily mean enormous revenues immediately, but it could provide: re-rating of the stock higher strategic interest better negotiating power with OEMs.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
70 päivää sitten
‧31 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 t sittenNow both turnover and the share price really picked up speed..
- ·3 t sittenOnce again, don't forget that Elabs changed quarterly reports so that Q1 is not representative of activity and revenues. They subsequently changed the Q4 report which was seemingly positive to become correspondingly very bad afterwards where this effect will have a positive impact on Q1 and 2026 as a whole. High-level accounting trickery where they in reality get a positive effect 2 times. See the same people time and again disregard this in an attempt at positive publicity, optimism probably with personal gain as the goal. Be careful. I myself hold shares here. That being said, it can be interesting if the company delivers positive results and gets more contracts where they actually earn money and which contribute to real growth in the company..The market value is seemingly low if they deliver growth, positive ebita over time and build cash.
- ·4 t sittenAny predictions for Q1 21.5? It looks like they are delivering growth towards 2025 and together with cost cuts, this should be good. Revenue Q1 2025 was 26,6MNOK and EBITDA -1,6 if I remember correctly.·2 t sitten · MuokattuTwo contracts have been signed in Q1. Lenovo and Transsion. I expect pretty much the same in Revenue as in 2025. Am more excited about Cash revenues for Q1. A lot of cash came in Q1 2025 (could be POC). Possibly it's the fixed-price contracts. also I have a hope that revenue from the POC contract that came in 2025, was in Q4 and thus can give 12,6 mill in cash now in Q1. But if both these "hopes" come true, and they get a lot of cash in Q1, then it's very strange to carry out an emi at such a low price, when extra income comes in the report right after. Edit: info about POC is on page 30 in the annual report
- ·22 t sittenIs there a rights issue coming here, has anyone caught anything? I can't find any info about this f, but it's taking an awfully long time? Info about the issue and possible rights issue probably came in early March. It must be said that I don't follow the company very closely anymore, but I saw that the share had a huge day yesterday, and started looking for info about this. It's fun when companies have green numbers, and then one gets curious :)·23 min sittenMajesty: What is stated in the annual report is not that something has been cancelled, it says, translated into Norwegian, slightly simplified: "The board of Elliptic Laboratories acknowledges that a private placement at a low price resulted in dilution for existing shareholders, but defends the transaction as necessary to secure low-risk capital. They believe this was in the common interest under prevailing market conditions" Common practice after a private placement is that the dilution is compensated with a repair issue, i.e., an opportunity for existing customers to "repair" some of the dilution by being able to buy shares on the same terms as those who participated in the private placement. The stock exchange has established guidelines for this, and they are quite strict about it. Nothing there about "the company has enough money, so they can choose to treat large and small shareholders differently". The share price in Elabs dipped under 2.85 but I don't know if that was enough for all shareholders to have been able to buy sufficient shares cheaper on the stock exchange than in the issue. We are talking about over 10 million shares in the repair issue, so it is of great importance whether the price was long enough below 2.85. This is what I'm wondering about, and the annual report doesn't say anything about this, it only says something about the considerations regarding dilution and the share price discount that was given. I think 30 mill kr in a repair issue is quite a lot to set as a plan, because the private placement was only double that. So I do believe the company sees a need for the money for something or other. It's not something you pull out of thin air, many other companies offer 20-25% in a repair issue, so they should have a need when they set it so high. If they hadn't had a need, they could have concluded with a much lower proportion for the private placement, and called this off quite shortly after the price dipped below, I think. It's wrong to say they don't need the money, we don't know that, there might be projects they want to realize in the future? New development costs a lot of money, as does work with new customers in the POC phase, which one hopes they are working on. There you get little in, but it costs a lot of expenses. I'm not going to talk down Elabs, just so that's clear, but I don't understand why there's a delay with information about the repair issue. It usually takes about 1 month, now 2 months have passed. Maybe they are waiting for prospectus approval from Finanstilsynet? Or it could be that it has been cancelled, but one usually gets a notification about that, it is essential information for shareholders. See for example Circio, where a repair issue of 25% of the private placement was cancelled due to the share price being 20% below the issue price: https://e24.no/bors/nyheter/a/304333 You can read more about the topic here: https://www.pwc.no/no/tjenester/kapitalmarkedstjenester/rettede-aksjeemisjoner.html·10 min sittenI interpret it as I described above and believe your translation does not capture all nuances. The time it has taken is a further argument against a repair issue now. The board has only been granted an authorization for such a repair issue and has never committed to carrying it out. Since over 10m shares traded around the issue price after publication, I would assume there is no obligation on the company to carry this out based on the principle of equal treatment. If they need more money, which I don't think they do right now, they have the authorization to raise money in other ways than a repair issue.
- ·1 päivä sittenThere are now quite strong rumors that Apple Inc. is considering using Intel Corporation Foundry as a supplement to Taiwan Semiconductor Manufacturing Company (TSMC) for parts of its Apple Silicon production. Currently, this is at the "exploratory talks" stage, but the market is taking it very seriously. For Elabs, this could potentially be quite important – indirectly. Here's why: 1. Apple would be an enormous quality validation of Intel Foundry If Apple actually places production with Intel, it practically means that Intel has proven: competitive yield stable production advanced node technology (18A / 18A-P / 14A) high enough energy efficiency and volume capacity This is exactly what Intel needs to become a serious competitor to TSMC again. For companies already "designed in" to the Intel ecosystem – as Elliptic Labs is with AI Sensor Platform / virtual smart sensors – this could provide: greater credibility faster adoption by OEMs more design wins higher probability of volume 2. Elabs is exposed to Intel's AI-PC initiative In recent years, Elliptic Labs has gained entry into several Intel-based laptop designs through: AI Virtual Presence Sensor Human presence detection Context awareness Ultrasound-based sensor solutions Intel has tried to build an "AI PC" ecosystem around Core Ultra / Lunar Lake / Panther Lake. If Apple chooses Intel Foundry, the market will suddenly see Intel as: technologically relevant again strategically important for the USA a possible winner in the AI-chip race This could lift the entire Intel ecosystem — including partners like Elliptic Labs. The effect is: "Intel gets stronger → Intel ecosystem gains higher value → Intel partners can gain greater commercial weight." 4. Potential multiple effect for the Elabs stock The market loves "second-order beneficiaries". If the narrative becomes: Apple validates Intel Foundry Intel becomes an AI-chip challenger again Intel PC platforms gain momentum, then investors might start looking closer at small Intel-associated companies. That's where Elliptic Labs fits in perfectly: small market cap AI-edge narrative software margins already commercialized technology shipping in large OEM volumes This doesn't necessarily mean enormous revenues immediately, but it could provide: re-rating of the stock higher strategic interest better negotiating power with OEMs.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 386 | - | - | ||
| 1 189 | - | - | ||
| 5 425 | - | - | ||
| 2 142 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 20.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
70 päivää sitten
‧31 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 20.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 t sittenNow both turnover and the share price really picked up speed..
- ·3 t sittenOnce again, don't forget that Elabs changed quarterly reports so that Q1 is not representative of activity and revenues. They subsequently changed the Q4 report which was seemingly positive to become correspondingly very bad afterwards where this effect will have a positive impact on Q1 and 2026 as a whole. High-level accounting trickery where they in reality get a positive effect 2 times. See the same people time and again disregard this in an attempt at positive publicity, optimism probably with personal gain as the goal. Be careful. I myself hold shares here. That being said, it can be interesting if the company delivers positive results and gets more contracts where they actually earn money and which contribute to real growth in the company..The market value is seemingly low if they deliver growth, positive ebita over time and build cash.
- ·4 t sittenAny predictions for Q1 21.5? It looks like they are delivering growth towards 2025 and together with cost cuts, this should be good. Revenue Q1 2025 was 26,6MNOK and EBITDA -1,6 if I remember correctly.·2 t sitten · MuokattuTwo contracts have been signed in Q1. Lenovo and Transsion. I expect pretty much the same in Revenue as in 2025. Am more excited about Cash revenues for Q1. A lot of cash came in Q1 2025 (could be POC). Possibly it's the fixed-price contracts. also I have a hope that revenue from the POC contract that came in 2025, was in Q4 and thus can give 12,6 mill in cash now in Q1. But if both these "hopes" come true, and they get a lot of cash in Q1, then it's very strange to carry out an emi at such a low price, when extra income comes in the report right after. Edit: info about POC is on page 30 in the annual report
- ·22 t sittenIs there a rights issue coming here, has anyone caught anything? I can't find any info about this f, but it's taking an awfully long time? Info about the issue and possible rights issue probably came in early March. It must be said that I don't follow the company very closely anymore, but I saw that the share had a huge day yesterday, and started looking for info about this. It's fun when companies have green numbers, and then one gets curious :)·23 min sittenMajesty: What is stated in the annual report is not that something has been cancelled, it says, translated into Norwegian, slightly simplified: "The board of Elliptic Laboratories acknowledges that a private placement at a low price resulted in dilution for existing shareholders, but defends the transaction as necessary to secure low-risk capital. They believe this was in the common interest under prevailing market conditions" Common practice after a private placement is that the dilution is compensated with a repair issue, i.e., an opportunity for existing customers to "repair" some of the dilution by being able to buy shares on the same terms as those who participated in the private placement. The stock exchange has established guidelines for this, and they are quite strict about it. Nothing there about "the company has enough money, so they can choose to treat large and small shareholders differently". The share price in Elabs dipped under 2.85 but I don't know if that was enough for all shareholders to have been able to buy sufficient shares cheaper on the stock exchange than in the issue. We are talking about over 10 million shares in the repair issue, so it is of great importance whether the price was long enough below 2.85. This is what I'm wondering about, and the annual report doesn't say anything about this, it only says something about the considerations regarding dilution and the share price discount that was given. I think 30 mill kr in a repair issue is quite a lot to set as a plan, because the private placement was only double that. So I do believe the company sees a need for the money for something or other. It's not something you pull out of thin air, many other companies offer 20-25% in a repair issue, so they should have a need when they set it so high. If they hadn't had a need, they could have concluded with a much lower proportion for the private placement, and called this off quite shortly after the price dipped below, I think. It's wrong to say they don't need the money, we don't know that, there might be projects they want to realize in the future? New development costs a lot of money, as does work with new customers in the POC phase, which one hopes they are working on. There you get little in, but it costs a lot of expenses. I'm not going to talk down Elabs, just so that's clear, but I don't understand why there's a delay with information about the repair issue. It usually takes about 1 month, now 2 months have passed. Maybe they are waiting for prospectus approval from Finanstilsynet? Or it could be that it has been cancelled, but one usually gets a notification about that, it is essential information for shareholders. See for example Circio, where a repair issue of 25% of the private placement was cancelled due to the share price being 20% below the issue price: https://e24.no/bors/nyheter/a/304333 You can read more about the topic here: https://www.pwc.no/no/tjenester/kapitalmarkedstjenester/rettede-aksjeemisjoner.html·10 min sittenI interpret it as I described above and believe your translation does not capture all nuances. The time it has taken is a further argument against a repair issue now. The board has only been granted an authorization for such a repair issue and has never committed to carrying it out. Since over 10m shares traded around the issue price after publication, I would assume there is no obligation on the company to carry this out based on the principle of equal treatment. If they need more money, which I don't think they do right now, they have the authorization to raise money in other ways than a repair issue.
- ·1 päivä sittenThere are now quite strong rumors that Apple Inc. is considering using Intel Corporation Foundry as a supplement to Taiwan Semiconductor Manufacturing Company (TSMC) for parts of its Apple Silicon production. Currently, this is at the "exploratory talks" stage, but the market is taking it very seriously. For Elabs, this could potentially be quite important – indirectly. Here's why: 1. Apple would be an enormous quality validation of Intel Foundry If Apple actually places production with Intel, it practically means that Intel has proven: competitive yield stable production advanced node technology (18A / 18A-P / 14A) high enough energy efficiency and volume capacity This is exactly what Intel needs to become a serious competitor to TSMC again. For companies already "designed in" to the Intel ecosystem – as Elliptic Labs is with AI Sensor Platform / virtual smart sensors – this could provide: greater credibility faster adoption by OEMs more design wins higher probability of volume 2. Elabs is exposed to Intel's AI-PC initiative In recent years, Elliptic Labs has gained entry into several Intel-based laptop designs through: AI Virtual Presence Sensor Human presence detection Context awareness Ultrasound-based sensor solutions Intel has tried to build an "AI PC" ecosystem around Core Ultra / Lunar Lake / Panther Lake. If Apple chooses Intel Foundry, the market will suddenly see Intel as: technologically relevant again strategically important for the USA a possible winner in the AI-chip race This could lift the entire Intel ecosystem — including partners like Elliptic Labs. The effect is: "Intel gets stronger → Intel ecosystem gains higher value → Intel partners can gain greater commercial weight." 4. Potential multiple effect for the Elabs stock The market loves "second-order beneficiaries". If the narrative becomes: Apple validates Intel Foundry Intel becomes an AI-chip challenger again Intel PC platforms gain momentum, then investors might start looking closer at small Intel-associated companies. That's where Elliptic Labs fits in perfectly: small market cap AI-edge narrative software margins already commercialized technology shipping in large OEM volumes This doesn't necessarily mean enormous revenues immediately, but it could provide: re-rating of the stock higher strategic interest better negotiating power with OEMs.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 386 | - | - | ||
| 1 189 | - | - | ||
| 5 425 | - | - | ||
| 2 142 | - | - |
Välittäjätilasto
Dataa ei löytynyt